Most Read Articles
14 Feb 2020
Chronic pancreatitis patients taking antioxidants (AO) supplementation show a sustained increase in blood levels of AO, but no additional benefit is seen on endocrine and exocrine functions, markers of fibrosis, oxidative stress (OS) and inflammation, nutritional status, pain, and quality of life (QOL) when compared with those on placebo, according to a study.
29 Nov 2019
Metformin Extended Release 500 mg,750 mg, and 1000 mg
01 Dec 2019
Pneumonia is a common infection– affecting around 3,200 people inSingapore in 2016 – making it the thirdmost common cause of hospitalisation inthe country. Its common complications,especially with delayed or inappropriatetreatment, include bacteraemia andseptic shock, lung abscesses, pleuraleffusions, empyema, pleurisy, respiratoryfailure and renal failure.
Stephen Padilla, 13 Feb 2020
A pharmacist intervention appears to be effective in lowering and preventing the incidence of prescribing errors of investigational drugs in oncology clinical trials, a recent study has shown.

Micronutrient levels vary in patients with Down syndrome

13 Aug 2017

Patients with Down syndrome (DS) have lower blood concentrations of zinc, selenium and calcium, and higher blood cell levels of copper and zinc, according to a systematic review.

Studies that measured micronutrient levels in whole blood, hair, saliva, red cell, serum and plasma samples of DS patients and controls were searched from the databases of PubMed, Web of Knowledge and Scopus. Those that measured protein and mRNA expression were excluded. A total of 69 studies met the inclusion criteria.

The Newcastle-Ottawa scale was used to assess methodological quality of the eligible observational studies. Information extracted from the studies included type of specimen, study sample characteristics, assay used and micronutrient levels.

Five comparisons (cases n=83; controls n=125) showed that red blood cell (RBC) levels of copper were significantly higher in patients with DS than in controls (standardized mean difference [SMD], 2.77; 95 percent CI, 1.96 to 3.57; p<0.00001).

Selenium concentration in the blood (SMD, -0.99; -1.55 to -0.43; p=0.0006), serum (SMD, -0.60; -0.97 to -0.23; p=0.001) and whole blood (SMD, -2.60; -3.32 to -1.89; p<0.00001) were significantly lower in DS cases.

Additionally, while blood calcium was significantly lower in DS cases (SMD, -0.63; -1.16 to -0.09; p=0.02), salivary levels were significantly higher (SMD, 0.85; 0.38 to 1.33; p=0.0004). Salivary sodium was significantly elevated in DS cases (SMD, 1.04; 0.39 to 1.69; p=0.002).

Blood (SMD, -1.30; -1.75 to -0.84; p<0.00001), plasma (SMD, -1.23; -1.93 to -0.54; p=0.0005), serum (SMD, -1.44; -1.93 to -0.95; p<0.00001) and hair (SMD, -0.54; -0.97 to -0.12; p=0.01) zinc concentrations were significantly lower in patients with DS, while RBC zinc (SMD, 2.62; 1.59 to 3.66; p<0.00001) was higher.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
14 Feb 2020
Chronic pancreatitis patients taking antioxidants (AO) supplementation show a sustained increase in blood levels of AO, but no additional benefit is seen on endocrine and exocrine functions, markers of fibrosis, oxidative stress (OS) and inflammation, nutritional status, pain, and quality of life (QOL) when compared with those on placebo, according to a study.
29 Nov 2019
Metformin Extended Release 500 mg,750 mg, and 1000 mg
01 Dec 2019
Pneumonia is a common infection– affecting around 3,200 people inSingapore in 2016 – making it the thirdmost common cause of hospitalisation inthe country. Its common complications,especially with delayed or inappropriatetreatment, include bacteraemia andseptic shock, lung abscesses, pleuraleffusions, empyema, pleurisy, respiratoryfailure and renal failure.
Stephen Padilla, 13 Feb 2020
A pharmacist intervention appears to be effective in lowering and preventing the incidence of prescribing errors of investigational drugs in oncology clinical trials, a recent study has shown.